arrow
P

Piyanuch Kongtim

Department of Medicine
H-index:24
Citation Count:2,159
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

From salvage therapy to survivorship: mapping the late effects of autologous stem cell transplantation in autoimmune disease

从挽救治疗到生存期:自体干细胞移植在自身免疫性疾病中晚期效应的映射

2026-08-040
PRE
Rapid HHV-6 Clearance Following Preemptive Short-Course Foscarnet in Allogeneic Stem Cell Transplant Recipients

异基因干细胞移植受者接受预防性短疗程福司卡奈特治疗后快速清除HHV-6

2026-04-130
PREAI
Optimal Pharmacokinetic Sampling Strategy for Melphalan-Based Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
2026-02-030
PRE
When the first graft fails: a strategic approach to donor selection for second transplant

当首次移植失败时:第二次移植供者选择的一种战略方法

2026-02-010
OAAI
Impact of Stem Cell Mobilization with Chemotherapy versus G-CSF Alone for Multiple Myeloma Patients with Suboptimal Response Before Autologous Stem Cell Transplant
2026-01-110
PRE
Efficacy of CD19 CAR T-cell therapy for patients with B-cell acute lymphoblastic leukemia relapsed after allogeneic transplantation

异基因移植后复发的B细胞急性淋巴细胞白血病患者CD19 CAR T细胞疗法的疗效

2026-01-010
PRE
Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell Carcinoma

了解转移性肾细胞癌管理中患者和肿瘤科医生的选择偏好

2026-01-010
OAAI
Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis

氟达拉滨-美法仑与氟达拉滨-白消安两种减低强度预处理方案在血液恶性肿瘤患者异基因造血干细胞移植中的效果:一项系统评价与荟萃分析

CANCER
IF5.1
2025-12-150
OA
Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7+3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia

Venetoclax联合克拉屈滨、伊达比星、阿糖胞苷(CLIA-VEN)在 newly diagnosed acute myeloid leukaemia 患者中可带来更高的缓解率,且未增加毒性,优于常规7+3化疗方案。

2025-11-010
OAAI
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation

布地奈德,添加到PTCy为基础的方案中,用于预防异基因干细胞移植后的急性胃肠道移植物抗宿主病

2025-01-080
PRE
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies
2024-12-013
PRE
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience

髓母细胞期CML患者的前期化疗强化: 单中心经验

2024-10-230
OAAI
Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection

早期冠状病毒病2019感染的异基因干细胞移植患者免疫重建持续受损和生存结局恶化

2024-08-010
PRE
Extending duration of letermovir prophylaxis in haploidentical stem cell transplantation
2024-07-110
OAAI
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML
2024-03-053
PRE
Adoptive cellular therapy after hematopoietic stem cell transplantation
2024-01-253
OAAI
Autologous hematopoietic stem cell transplantation for a patient with multiple autoimmune diseases
2023-07-082
OAAI
Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
2023-06-019
OAAI
Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia
2023-02-242
OA
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation
CANCER
IF5.1
2023-02-040
PRE